Purinoscience Overview
- Status
-
Private
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
3
Purinoscience General Information
Description
Developer of oral medications designed to assist in muscle strength and mobility. The company offers small-molecule drugs and functional foods aimed at preventing sarcopenia and cognitive decline, enabling patients to get access to novel therapeutics that target age-related diseases.
Contact Information
Corporate Office
- Bunkyo City
- Japan
Corporate Office
- Bunkyo City
- Japan
Purinoscience Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Accelerator/Incubator | 27-Mar-2026 | Completed | Startup | |||
| 2. Accelerator/Incubator | 25-Dec-2025 | Completed | Startup | |||
| 1. Accelerator/Incubator | 03-Sep-2025 | Completed | Startup |
Purinoscience Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| FASTAR | Accelerator/Incubator | |||
| NQ Global Startup Gateway | Accelerator/Incubator | |||
| MEDISO | Accelerator/Incubator |
Purinoscience FAQs
-
Where is Purinoscience headquartered?
Purinoscience is headquartered in Bunkyo City, Japan.
-
What industry is Purinoscience in?
Purinoscience’s primary industry is Pharmaceuticals.
-
Is Purinoscience a private or public company?
Purinoscience is a Private company.
-
What is Purinoscience’s current revenue?
The current revenue for Purinoscience is .
-
Who are Purinoscience’s investors?
FASTAR, NQ Global Startup Gateway, and MEDISO have invested in Purinoscience.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process